HIKAL. Fact Sheet, HIKAL. Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL. Fact Sheet   (HKCH)


Register Now: Our Mega Summit Goes LIVE at 5pm Today


Here is the latest financial fact sheet of HIKAL.. For more details, see the HIKAL. quarterly results and HIKAL. share price and chart. For a sector overview, read our pharmaceuticals sector report.

HIKAL. Price History

Price Rs 237.6
Mkt Cap Rs m 29,296
Vol '000 75.8
P/E X 18.3
P/CF X 13.4
EPS (TTM) Rs 13.0
1 Day % -4.7
No. of shares m 123.30
1 Week % 0.6
1 Month % -32.8
1 Year % -50.5
52 week H/L Rs 742.0/215.7
As on Jun 30, 2022 03:29:00 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

HIKAL. Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
HIKAL. EQUITY SHARE DATA
High Rs256265265187204 
Low Rs1171951355767 
Sales per share (Unadj.) Rs120.9157.2128.9122.2139.5 
Earnings per share (Unadj.) Rs8.29.48.46.810.8 
Diluted earnings per shareRs5.56.38.46.810.8 
Cash flow per share (Unadj.) Rs16.619.815.913.517.7 
Dividends per share (Unadj.) Rs1.201.201.201.202.00 
Adj. dividends per shareRs0.800.801.201.202.00 
Avg Dividend yield %0.60.50.61.01.5 
Book value per share (Unadj.) Rs73.681.461.366.275.7 
Adj. book value per shareRs49.154.361.366.275.7 
Shares outstanding (eoy) m82.2082.20123.30123.30123.30 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x1.51.51.61.01.0 
Avg P/E ratio x22.624.523.917.812.6 
P/CF ratio (eoy) x11.211.612.69.07.7 
Price / Book Value ratio x2.52.83.31.81.8 
Dividend payout %14.612.814.417.518.5 
Avg Mkt Cap Rs m15,33518,90224,68215,05216,738 
No. of employees `000NANANANANA 
Total wages/salary Rs m1,1671,2811,3571,5661,643 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
HIKAL. INCOME DATA
Net Sales Rs m9,93912,92115,89615,07317,204 
Other income Rs m3445233750 
Total revenues Rs m9,97312,96615,91915,11017,254 
Gross profit Rs m1,9422,4172,9812,5783,229 
Depreciation Rs m691856929825852 
Interest Rs m483491584524362 
Profit before tax Rs m8031,1151,4911,2662,064 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m125343460421733 
Profit after tax Rs m6777721,0318441,331 
Gross profit margin %19.518.718.817.118.8 
Effective tax rate %15.630.730.933.335.5 
Net profit margin %6.86.06.55.67.7 
HIKAL. BALANCE SHEET DATA
Current assets Rs m6,0687,4618,8658,3129,251 
Current liabilities Rs m4,7036,1626,5906,5287,033 
Net working cap to sales %13.710.114.311.812.9 
Current ratio x1.31.21.31.31.3 
Inventory Days Days2328223726 
Debtors Days Days94818082103 
Net fixed assets Rs m7,9278,5138,88210,48210,906 
Share capital Rs m164164247247247 
"Free" reserves Rs m5,8856,5297,3167,9189,087 
Net worth Rs m6,0506,6947,5628,1659,334 
Long term debt Rs m3,2022,9662,9783,0342,629 
Total assets Rs m13,99515,97417,74718,79420,157 
Interest coverage x2.73.33.63.46.7 
Debt to equity ratio x0.50.40.40.40.3 
Sales to assets ratio x0.70.80.90.80.9 
Return on assets %8.37.99.17.38.4 
Return on equity %11.211.513.610.314.3 
Return on capital %13.916.619.716.020.3 
Exports to sales %66.570.569.672.368.7 
Imports to sales %30.136.537.129.726.9 
Exports (fob) Rs m6,6129,11511,05610,89211,823 
Imports (cif) Rs m2,9964,7215,8934,4764,623 
Fx inflow Rs m6,6129,11511,05610,89211,823 
Fx outflow Rs m3,3044,7215,8934,4764,623 
Net fx Rs m3,3084,3945,1636,4167,200 
HIKAL. CASH FLOW
From Operations Rs m 1,635 1,388 1,856 2,849 2,290 
From Investments Rs m -1,022 -1,101 -1,246 -1,638 -1,562 
From Financial Activity Rs m -633 -248 -554 -1,009 -969 
Net Cashflow Rs m -20 39 56 203 -240 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 68.8%
Institution 7.8%
Non-Institution 23.4%
Total 100.0%
Free Float 31.2%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off 717, Maker Chambers V, Nariman Point, Mumbai - 400021
E-mail info@hikal.com/secretarial@hikal.com Web www.hikal.com
Tel 022-39267100/62770477 Fax 022-22833913
Sector PHARMACEUTICALS Group KALYANI
Tr Agent Universal Capital Securities Ltd., C 101 247 Park, LBS Road, Vikhroli West
CHM: Jai Hiremath COMP SEC: Rajasekhar Reddy YEAR OF INC: 1988 BSE CODE: 524735 FV (Rs): 2 DIV YIELD (%): 0.8

Read: HIKAL. 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare HIKAL. With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    




Today's Market

Indian Share Markets End Flat; Tech Mahindra, IndusInd Bank & Bajaj Finance Top Losers(Closing)

Indian share markets traded in a rangebound fashion throughout the day today to end flat.

Views on news

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

Is it Time to Start Buying Stocks Selectively? (Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

The One Smallcap Stock I'll Recommend Now (Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

The Greatest Dividend Stock of All Time is... (Views On News)

Jun 16, 2022

Prudent investors should consider dividend aristocrats to create passive, predictable, and growing income to rely on whether the market moves up or down in these uncertain times.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK HIKAL.

MORE ON HIKAL.

HIKAL. - KAMRON LABORATORIES COMPARISON

COMPARE HIKAL. WITH

MARKET STATS